Recursion Pharmaceuticals Receives $4M Credit Facility from Square 1 Bank

recursionRecursion Pharmaceuticals, Inc., a Salt Lake City-based pharmaceutical discovery company, received a $4m credit facility.

Square 1 Bank, a division of Pacific Western Bank, provided the financing.

The company intends to use the proceeds to purchase new equipment and supplement its recent $15.05 Series A round of funding.

Led by John Pereira, chief operating officer, Chistopher C. Gibson, PhD, Co-Founder & CEO, Blake Borgeson, PhD, Co-Founder & CTO, Recursion Pharmaceuticals leverages advanced biological science, computation and artificial intelligence to provide a platform that discovers treatments for rare genetic disease and other conditions including aging, inflammation, infectious disease, oncology, and diagnostics, which can be modeled in human cells.



Join the discussion